Toronto 
Novel Coronavirus SARS-CoV-2; Credit: National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH
Toronto Public Health has announced that a patient who has tested positive for COVID-19 travelled on the TTC on Mon., Mar. 2, Tues., Mar. 3 and Wed., Mar. 4.
The man in his 40s returned from Las Vegas, Nevada on February 28. He took TTC and MiWay while he was experiencing symptoms.
Dr. Eileen de Villa, Toronto’s Chief Medical Officer of Health said the man rode the subway from Bathurst to Islington stations on March 2 and 3 at about 8:50 a.m. He then used 108 Mississauga MiWay 108N express bus from Islington Station.
At about 6:10 p.m., he also travelled on 27 Milton GO bus to Yorkdale TTC Station and then on the subway to St. George Station by 6:45 p.m.
Dr. Eileen de Villa also said that he took the 511 Bathurst streetcar from Bathurst Station around 7 p.m. on Wed., Mar. 4.
Based on information gathered about this individual’s travel patterns, the TTC is in the process of identifying specific vehicles that the individual rode on the days indicated above. Toronto Public Health has assured that TTC and the city that the risk of exposure for both TTC employees and customers remains low.
TTC has been performing significant additional cleaning and disinfection of all public places with a focus on touch and grab points, such as buttons, railings, handles and straps. TTC has assured that TTC continues to be a safe method of travel.
A 34 year-old Richmond Hill woman was symptomatic while travelling on GO Bus 40, last month. No related cases were reported due to her travel without a mask.
With the global cases of COVID-19 topping 100,000 with more than three thousand deaths, Government of Canada has increased coronavirus research funding to $27 million from 7 million.
Currently in Canada, the total positive COVID-19 cases stand at 51, with 21 cases in British Columbia, 1 in Alberta, 26 in Ontario and 3 in Quebec. Of these 51, 8 cases, 4 each in B.C. and Ontario were fully resolved, with each of those patients having two consecutive negative tests at least 24 hours apart.
